143 companies
Madrigal Pharmaceuticals
Market Cap: US$11.5b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$497.27
7D
-3.9%
1Y
82.4%
Infinity Natural Resources
Market Cap: US$860.9m
Engages in the acquisition, exploration, and development of properties to produce crude oil, natural gas, and natural gas liquids in the United States.
INR
US$13.55
7D
-6.6%
1Y
-20.5%
Lumentum Holdings
Market Cap: US$66.5b
Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.
LITE
US$854.96
7D
-9.7%
1Y
1,027.0%
Zevra Therapeutics
Market Cap: US$685.1m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.59
7D
15.6%
1Y
33.8%
Travere Therapeutics
Market Cap: US$4.4b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$47.18
7D
6.2%
1Y
204.0%
Syndax Pharmaceuticals
Market Cap: US$1.7b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$19.59
7D
-1.8%
1Y
78.4%
PicS
Market Cap: US$1.4b
Operates as a digital financial services company that provides digital wallet and application for individuals and businesses in Brazil.
PICS
US$10.59
7D
-4.2%
1Y
n/a
AppLovin
Market Cap: US$206.0b
Provides end-to-end artificial intelligence-powered advertising solutions for businesses in the United States and internationally.
APP
US$613.09
7D
27.3%
1Y
52.5%
AnaptysBio
Market Cap: US$1.6b
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.
ANAB
US$55.67
7D
-6.8%
1Y
154.7%
Ardelyx
Market Cap: US$1.5b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$6.04
7D
-1.1%
1Y
56.9%
Alignment Healthcare
Market Cap: US$3.2b
Operates a consumer-centric healthcare platform for seniors in the United States.
ALHC
US$15.32
7D
-6.3%
1Y
-1.2%
AGI
Market Cap: US$1.2b
Provides technology-powered specialized financial services in Brazil.
AGBK
US$7.20
7D
1.3%
1Y
n/a
WaterBridge Infrastructure
Market Cap: US$3.6b
WaterBridge Infrastructure LLC, water infrastructure company, provides water management solutions through integrated pipeline and water handling networks in the United States.
WBI
US$29.25
7D
-6.1%
1Y
n/a
Oracle
Market Cap: US$649.4b
Offers products and services that address enterprise information technology environments worldwide.
ORCL
US$225.78
7D
17.5%
1Y
35.5%
FTAI Aviation
Market Cap: US$26.7b
Owns, acquires, and sells aviation equipment for the transportation of goods and people worldwide.
FTAI
US$260.34
7D
3.3%
1Y
116.3%
Abeona Therapeutics
Market Cap: US$329.4m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$5.78
7D
6.3%
1Y
-8.0%
McEwen
Market Cap: US$1.3b
Engages in the exploration, development, production, and sale of gold and silver deposits in the United States, Canada, Mexico, and Argentina.
MUX
US$21.89
7D
3.5%
1Y
153.9%
FirstSun Capital Bancorp
Market Cap: US$1.7b
Operates as the bank holding company for Sunflower Bank, National Association that provides commercial and consumer banking and financial services to small and medium-sized companies in the United States.
FSUN
US$35.45
7D
0.03%
1Y
0.6%
Compass
Market Cap: US$6.1b
Provides an end-to-end technology platform for residential real estate in the United States.
COMP
US$8.23
7D
-2.0%
1Y
40.9%
UroGen Pharma
Market Cap: US$1.4b
A biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$28.13
7D
-2.6%
1Y
481.2%
Capricor Therapeutics
Market Cap: US$1.7b
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$29.96
7D
3.8%
1Y
193.4%
ARS Pharmaceuticals
Market Cap: US$900.7m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.
SPRY
US$9.07
7D
14.2%
1Y
-37.3%
Luckin Coffee
Market Cap: US$10.4b
Offers retail services of freshly brewed drinks, and pre-made food and beverage items in the People's Republic of China.
LKNC.Y
US$32.16
7D
2.7%
1Y
0.09%
Pelthos Therapeutics
Market Cap: US$92.0m
A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
PTHS
US$26.47
7D
-0.7%
1Y
159.5%
Pagaya Technologies
Market Cap: US$1.3b
A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services, their customers, and institutional or sophisticated investors in the United States, Israel, and the Cayman Islands.
PGY
US$15.12
7D
18.5%
1Y
-9.6%
AVITA Medical
Market Cap: US$133.3m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$4.33
7D
-5.5%
1Y
-28.3%
Zscaler
Market Cap: US$22.6b
Operates as a cloud security company worldwide.
ZS
US$139.73
7D
-23.4%
1Y
-52.3%
Aldeyra Therapeutics
Market Cap: US$105.6m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
ALDX
US$1.75
7D
12.9%
1Y
-17.5%
Daqo New Energy
Market Cap: US$1.1b
Manufactures and sells polysilicon to photovoltaic product manufacturers in the People’s Republic of China.
DQ
US$16.64
7D
-6.4%
1Y
27.5%
Intapp
Market Cap: US$1.8b
Through its subsidiary, Integration Appliance, Inc., provides AI-powered solutions in the United States, the United Kingdom, and internationally.
INTA
US$23.09
7D
13.2%
1Y
-58.5%
Gossamer Bio
Market Cap: US$54.2m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.
GOSS
US$0.23
7D
9.9%
1Y
-80.0%
Arcutis Biotherapeutics
Market Cap: US$2.7b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$21.46
7D
2.9%
1Y
59.2%
CG Oncology
Market Cap: US$5.5b
A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.
CGON
US$62.29
7D
-3.1%
1Y
134.3%
Wix.com
Market Cap: US$2.3b
Operates a cloud-based web development platform for registered users and creators in the United States, Europe, Israel, and internationally.
WIX
US$56.06
7D
5.4%
1Y
-62.4%
Simmons First National
Market Cap: US$3.1b
Operates as the bank holding company for Simmons Bank that provides banking and other financial products and services to individuals and businesses.
SFNC
US$21.45
7D
0.5%
1Y
15.8%
Atlassian
Market Cap: US$27.3b
Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.
TEAM
US$107.61
7D
26.0%
1Y
-47.7%